New Issue: Orbital Catastrophe Ahead? Read Now

Ozone Linked to Hardening Arteries

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Ozone is perhaps best known for its role in protecting the earth from solar radiation. But scientists recently discovered that the extremely reactive form of oxygen is produced by the human immune system as part of its defense strategy. New findings published in the journal Science suggest that such ozone production could contribute to atherosclerosis, the disease commonly known as hardening of the arteries that increases the risk of heart attacks and strokes.

As atherosclerosis develops, inflammation fuels the growth of plaques in the arteries. Paul Wentworth, Jr. and Richard Lerner of the Scripps Research Institute and their colleagues theorized that the fat-laden deposits that are hallmarks of the disease have all the necessary ingredients to manufacture ozone. "Ozone is damaging, and it is really a problem that we are going to have to think about in the next few years," Wentworth notes. "There may be a whole slew of molecules that ozone generates that we have never thought about before." The researchers analyzed plaque samples removed from patients suffering from coronary artery disease and found two compounds--dubbed atheronals by the authors--that are signature byproducts of ozone's interaction with cholesterol, forms of which have long been associated with atherosclerosis. The team writes that "it seems likely that ozone is generated throughout the evolution of the disease."

The researchers also detected one of the atheronal compounds in blood taken from patients suffering from late-stage atherosclerosis. Because the molecule is not present in healthy individuals, the scientists suggest that it could one day form the basis of a new diagnostic test for coronary artery disease.

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe